Aktis Oncology is aiming to bring in $182 million—or more—from what looks set to be the first biotech IPO of 2026. The company, which has accrued an impressive list of Big Pharma backers in its ...

SpaceX is poised for a blockbuster initial public offering in 2026, with CEO Elon Musk aiming to raise $30 billion in fresh capital. This would eclipse the record set by Saudi Aramco's 2019 IPO, which ...

Andersen Group ANDG3.25%increase; green up pointing triangle is a publicly held company now, two decades after the criminal conviction of its namesake accounting firm, Arthur Andersen, was overturned ...

Chinese companies developing reusable commercial ⁠rockets will have access to a fast lane for initial public offerings on the tech-heavy STAR market that exempts them ‍from some financial requirements ...

Why the IPO market took off in 2025. In this podcast, Motley Fool analysts Emily Flippen and Sanmeet Deo and contirubtor Jason Hall break down why the IPO market took off in 2025, which new listings ...

Alphabet-backed Motive Gears Up for IPO Amid AI Expansion and Legal Battles Your email has been sent The San Francisco-based company had previously filed confidentially and is now moving ahead with a ...

Chinese chipmakers are rushing to the IPO market, raising funds that are key to the nation’s goal of technological self-reliance and winning the global race on artificial intelligence. The surge in ...

SpaceX has confirmed a target IPO date of 2026. The company may reach an IPO valuation of $1.5 trillion. At that price, SpaceX will sell for more than 60x current-year sales. Where to invest $1,000 ...

Medline is now on Nasdaq. Medline raised $6.26 billion in the largest US IPO since 2021. Overwhelming demand led to an upsized offering of 216 million shares. Medline offers 190,000 products, 43,000 ...

Elon Musk is signaling a potential SpaceX IPO that could value the company between $1.5 trillion and $2 trillion, with an initial public offering size near $30 billion. A SpaceX listing could reignite ...

SpaceX employees have been told to keep mum about the company’s plans for a possible IPO, but that isn’t stopping Wall Street from buzzing about what could become its biggest payday in years, On The ...

Medline CEO Jim Boyle (R) celebrates after ringing the opening bell at Nasdaq Marketsite headquarters on Dec. 17, 2025. Photo by Michael M. Santiago/Getty Images A blockbuster IPO from an ...